NCT06663410View on ClinicalTrials.gov

Sphenopalatine Ganglion Block with Tx360 for Trigeminal Neuralgia

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

February 28, 2021

Primary Completion Date

April 15, 2024

Study Completion Date

April 15, 2024

Conditions
Trigeminal Neuralgia
Interventions
DEVICE

SPG block with the use of the Tx360 device

A SPG block was performed using the Tx360 nasal applicator according to the manufacturer's instructions bilaterally, injecting 0.3cc of lidocaine 2% into each nostril.

Trial Locations (1)

11528

Aretaieio Hospital, National and Kapodistrian University of Athens, Athens

All Listed Sponsors
lead

Aretaieio Hospital

OTHER

NCT06663410 - Sphenopalatine Ganglion Block with Tx360 for Trigeminal Neuralgia | Biotech Hunter | Biotech Hunter